Hydroxychloroquine in Covid-19: Does the end justify the means?

Yakoub-Agha, Ibrahim

Yakoub-Agha, Ibrahim.

Yakoub-Agha I; CHU de Lille, univ Lille, INSERM U1286, 59000 Lille, France. Electronic address: Ibrahim.yakoubagha@chru-lille.fr.

Curr Res Transl Med ; 68(3): 81-82, 2020 08.

Article in English | MEDLINE | ID: covidwho-72321

Subject(s)

Antibody Formation/drug effects; Coronavirus Infections/drug therapy; Coronavirus Infections/immunology; Hydroxychloroquine/adverse effects; Immunity, Cellular/drug effects; Immunity, Herd/drug effects; Pneumonia, Viral/drug therapy; Pneumonia, Viral/immunology; Antiviral Agents/therapeutic use; Azithromycin/administration & dosage; Azithromycin/adverse effects; Betacoronavirus/drug effects; Betacoronavirus/physiology; COVID-19; Cardiovascular Diseases/chemically induced; Cardiovascular Diseases/epidemiology; Coronavirus Infections/complications; Coronavirus Infections/epidemiology; Drug Therapy, Combination/adverse effects; Humans; Hydroxychloroquine/administration & dosage; Hydroxychloroquine/pharmacology; Immunosuppressive Agents/adverse effects; Immunosuppressive Agents/therapeutic use; Pandemics; Pneumonia, Viral/complications; Pneumonia, Viral/epidemiology; SARS-CoV-2; Viral Load/drug effects; Viral Vaccines/therapeutic use; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Immunity, Herd / Hydroxychloroquine / Immunity, Cellular / Antibody Formation Type of study: Observational study Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Curr Res Transl Med Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google